Compare BIIB & GDDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BIIB | GDDY |
|---|---|---|
| Founded | 1978 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.1B | 12.5B |
| IPO Year | 1996 | 2014 |
| Metric | BIIB | GDDY |
|---|---|---|
| Price | $182.19 | $82.40 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 27 | 17 |
| Target Price | ★ $195.00 | $142.00 |
| AVG Volume (30 Days) | 718.8K | ★ 1.9M |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 8.79 | 6.22 |
| Revenue | ★ $9,890,600,000.00 | N/A |
| Revenue This Year | N/A | $7.98 |
| Revenue Next Year | N/A | $6.06 |
| P/E Ratio | $21.36 | ★ $13.18 |
| Revenue Growth | ★ 2.22 | N/A |
| 52 Week Low | $110.04 | $73.06 |
| 52 Week High | $202.41 | $193.55 |
| Indicator | BIIB | GDDY |
|---|---|---|
| Relative Strength Index (RSI) | 46.01 | 42.53 |
| Support Level | $181.24 | $80.42 |
| Resistance Level | $184.16 | $93.65 |
| Average True Range (ATR) | 4.77 | 3.26 |
| MACD | -0.05 | 0.28 |
| Stochastic Oscillator | 51.29 | 38.73 |
Biogen is an established biopharmaceutical company focused on treatments for neurodegenerative and rare diseases. Its declining multiple sclerosis franchise is its largest revenue generator and contributed 40% of total revenue in 2025. Biogen also generates significant revenue from its CD20 collaboration agreements with Roche (19% of total in 2025), which includes oncology drugs Rituxan and Gazyva and multiple sclerosis drug Ocrevus. Biogen's newer franchises include Spinraza (spinal muscular atrophy, with partner Ionis), Leqembi (Alzheimer's disease, collabroation revenue from its partner Eisai), Skyclarys (Friedreich's ataxia, Reata), Zurzuvae (postpartum depression, Sage), and Qalsody (amyotrophic lateral sclerosis, Ionis).
GoDaddy Inc provides digital solutions and services for entrepreneurs, small businesses, individuals, organizations, developers, designers, and domain investors. It offers tools intended to support business creation and management through an integrated service platform. The company operates through two segments: Applications and Commerce (A&C) and Core Platform (Core). The majority of the company's revenue is derived from the Core Platform segment, which consists of sales of domain registrations and renewals, aftermarket domain sales, website hosting products and website security products. Geographically, it generates the maximum revenue from the United States.